Using Microfluidic Separation Sperm Selection for Unexplained Infertility and Reccurrent Implantation Failure
The Effects of Using Microfluidic Separation Sperm Selection for Unexplained Infertility(UEI) and Reccurrent Implantation Failure(RIF)
1 other identifier
interventional
200
1 country
1
Brief Summary
In order to increase the likelihood of achieving IVF-treated pregnancy, good quality embryo transfer is important. To get good quality embryos, good quality gametes are needed. The selection of sperm is regulated according to the changing and mobility characteristics of today's conditions. The choice of multi-fluid sperm is thought to provide better sperm to obtain the environment in physiological conditions. Better embryo transfer to achieve better sperm elongation will increase the likelihood of pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2017
CompletedFirst Posted
Study publicly available on registry
November 29, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedNovember 29, 2017
November 1, 2017
1.5 years
November 15, 2017
November 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Clinical Pregnancy Rate
Clinical pregnancy includes intrauterine gestation (pres- ence of a gestational sac on ultrasonography), ectopic preg- nancy, and miscarriage diagnosed by histology.Cycles with only a positive pregnancy test (biochemical pregnancy) are not considered to have a clinical pregnancy.
36 month
Live Birth Rate
A delivery is the birth of one or more infants, either living or not, after 20 weeks of gestation. A live birth is a delivery that results in at least one living infant
36 month
Abortion Rate
Pregnancy loss includes miscarriage and therapeutic abor- tion of a clinical intrauterine pregnancy occurring at %20 weeks of gestation.
36 month
Implantation Rate
Implantation rate is the number of gestational sacs observed on ultrasonog- raphy, divided by the number of embryos transferred.
36 month
Study Arms (4)
UEI Sperm Chip (-)
ACTIVE COMPARATORConventional IVF treatment and using conventional sperm selection
UEI Sperm Chip (+)
EXPERIMENTALConventional IVF treatment and using sperm chip for sperm selection
RIF sperm chip (-)
ACTIVE COMPARATORConventional IVF treatment and using conventional sperm selection
RIF sperm chip (+)
EXPERIMENTALConventional IVF treatment and using sperm chip for sperm selection
Interventions
Sperm selection using by conventional or with sperm chip
Eligibility Criteria
You may qualify if:
- normal HSG,
- normal hormone levels,
- normal over functions,
- having normal uterine cavity and endometrial thickness determined by office hysteroscopy
- no endometriosis (determined by transvaginal ultrasonography and / or diagnostic laparoscopy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Acibadem Fulya Hospital
Istanbul, Besiktas, 34349, Turkey (Türkiye)
Related Publications (1)
Tasoglu S, Safaee H, Zhang X, Kingsley JL, Catalano PN, Gurkan UA, Nureddin A, Kayaalp E, Anchan RM, Maas RL, Tuzel E, Demirci U. Exhaustion of racing sperm in nature-mimicking microfluidic channels during sorting. Small. 2013 Oct 25;9(20):3374-84. doi: 10.1002/smll.201300020. Epub 2013 May 16.
PMID: 23677651RESULT
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal İnvestigator
Study Record Dates
First Submitted
November 15, 2017
First Posted
November 29, 2017
Study Start
January 1, 2018
Primary Completion
June 30, 2019
Study Completion
December 31, 2019
Last Updated
November 29, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share